RemeGen Co., Ltd. (REGMF)
12.05
0.00 (0.00%)
USD |
OTCM |
Jun 01, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.790B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 138.1% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 11.94 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 90.40% |
Profile
| RemeGen Co., Ltd. is a biopharmaceutical company. It discovers, develops and commercializes biologics for the treatment of autoimmune, oncology, and ophthalmic diseases. The company was founded by Dr. Jianmin Fang and Wang Weidong on July 04, 2008 and is headquartered in Yantai, China. |
| URL | http://www.remegen.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shandong |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 20, 2026 (est.) |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| RemeGen Co., Ltd. is a biopharmaceutical company. It discovers, develops and commercializes biologics for the treatment of autoimmune, oncology, and ophthalmic diseases. The company was founded by Dr. Jianmin Fang and Wang Weidong on July 04, 2008 and is headquartered in Yantai, China. |
| URL | http://www.remegen.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shandong |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 20, 2026 (est.) |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |